SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (9988)4/3/2007 11:32:54 AM
From: Robohogs  Read Replies (1) of 10280
 
L 135,679
X MDI 57,343

See commentary in earlier post for L. For MDI, HFA units and share of albuterol mkt off somewhat sharply this week on the back of very strong unit losses by Teva - do not know which drove which. Did slowdown in Teva substitution slow down shift to HFA or did HFA shift slow down Teva? Both proventil and Xopenex gained sharply in the HFA market although proventil was a bit stronger and maintains a 4% share lead.

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext